Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Lang

Showing results (271-280 of 312) with videos related to

Pageof 32
Sort By:
Klinische Padiatrie|May 9, 2025
GPOH Guidelines for Diagnosis and First-line Treatment of Patients with Neuroblastic Tumors, update 2025Thorsten Simon, Theresa Thole, Sveva Castelli, et al.
Journal of Personalized Medicine|August 27, 2021
Neuroblastoma Risk Assessment and Treatment Stratification with Hybrid Capture-Based Panel SequencingAnnabell Szymansky, Louisa-Marie Kruetzfeldt, Lukas C Heukamp, et al.
Bone Marrow Transplantation|May 29, 2026
A pilot study combining primary busulfan-based haploidentical stem cell transplantation with GD2 antibody to treat high-risk neuroblastomaSveva Castelli, Tim Flaadt, Franziska Schulze, et al.
Journal of Medical Virology|December 3, 2024
Elevated Soluble ACE2 Activity in Children and Adults After SARS-CoV-2 Exposure Irrespective of Laboratory-Confirmed InfectionMaximilian Stich, Vladimir Gonçalves Magalhães, Friederike Bürger, et al.
British Journal of Haematology|December 2, 2017
Outcome of relapse after allogeneic HSCT in children with ALL enrolled in the ALL-SCT 2003/2007 trialMichaela Kuhlen, Andre M Willasch, Jean-Hugues Dalle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2015
Stem-cell transplantation in children with acute lymphoblastic leukemia: A prospective international multicenter trial comparing sibling donors with matched unrelated donors-The ALL-SCT-BFM-2003 trialChristina Peters, Martin Schrappe, Arend von Stackelberg, et al.
Pediatric Blood & Cancer|July 4, 2020
Risk factors for mixed chimerism in children with hemophagocytic lymphohistiocytosis after reduced toxicity conditioningKatharina Wustrau, Johann Greil, Karl-Walter Sykora, et al.
Blood Advances|April 29, 2020
Favorable outcomes of hematopoietic stem cell transplantation in children and adolescents with Diamond-Blackfan anemiaBrigitte Strahm, Felicia Loewecke, Charlotte M Niemeyer, et al.
American Journal of Hematology|May 17, 2019
Allogeneic hematopoietic stem cell transplantation from unrelated donors is associated with higher infection rates in children with acute lymphoblastic leukemia-A prospective international multicenter trial on behalf of the BFM-SG and the EBMT-PDWPHerbert Pichler, Anita Lawitschka, Evgenia Glogova, et al.
Leukemia|August 2, 2024
Rational combinatorial targeting by adapter CAR-T-cells (AdCAR-T) prevents antigen escape in acute myeloid leukemiaDaniel Atar, Lara Ruoff, Anna-Sophia Mast, et al.
Pageof 32

Showing results (271-280 of 312) with videos related to

Sort By:
Pageof 32
Klinische Padiatrie|May 9, 2025
GPOH Guidelines for Diagnosis and First-line Treatment of Patients with Neuroblastic Tumors, update 2025Thorsten Simon, Theresa Thole, Sveva Castelli, et al.
Journal of Personalized Medicine|August 27, 2021
Neuroblastoma Risk Assessment and Treatment Stratification with Hybrid Capture-Based Panel SequencingAnnabell Szymansky, Louisa-Marie Kruetzfeldt, Lukas C Heukamp, et al.
Bone Marrow Transplantation|May 29, 2026
A pilot study combining primary busulfan-based haploidentical stem cell transplantation with GD2 antibody to treat high-risk neuroblastomaSveva Castelli, Tim Flaadt, Franziska Schulze, et al.
Journal of Medical Virology|December 3, 2024
Elevated Soluble ACE2 Activity in Children and Adults After SARS-CoV-2 Exposure Irrespective of Laboratory-Confirmed InfectionMaximilian Stich, Vladimir Gonçalves Magalhães, Friederike Bürger, et al.
British Journal of Haematology|December 2, 2017
Outcome of relapse after allogeneic HSCT in children with ALL enrolled in the ALL-SCT 2003/2007 trialMichaela Kuhlen, Andre M Willasch, Jean-Hugues Dalle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 2015
Stem-cell transplantation in children with acute lymphoblastic leukemia: A prospective international multicenter trial comparing sibling donors with matched unrelated donors-The ALL-SCT-BFM-2003 trialChristina Peters, Martin Schrappe, Arend von Stackelberg, et al.
Pediatric Blood & Cancer|July 4, 2020
Risk factors for mixed chimerism in children with hemophagocytic lymphohistiocytosis after reduced toxicity conditioningKatharina Wustrau, Johann Greil, Karl-Walter Sykora, et al.
Blood Advances|April 29, 2020
Favorable outcomes of hematopoietic stem cell transplantation in children and adolescents with Diamond-Blackfan anemiaBrigitte Strahm, Felicia Loewecke, Charlotte M Niemeyer, et al.
American Journal of Hematology|May 17, 2019
Allogeneic hematopoietic stem cell transplantation from unrelated donors is associated with higher infection rates in children with acute lymphoblastic leukemia-A prospective international multicenter trial on behalf of the BFM-SG and the EBMT-PDWPHerbert Pichler, Anita Lawitschka, Evgenia Glogova, et al.
Leukemia|August 2, 2024
Rational combinatorial targeting by adapter CAR-T-cells (AdCAR-T) prevents antigen escape in acute myeloid leukemiaDaniel Atar, Lara Ruoff, Anna-Sophia Mast, et al.
Pageof 32